USA flag logo/image

An Official Website of the United States Government

Company Information:

Name: KINETA, INC.
Address: 219 Terry Ave N. Suite 300
SEATTLE, WA
Located in HUBZone: No
Woman-Owned: No
Minority-Owned: No
URL: N/A
Phone: N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $1,184,750.00 2
SBIR Phase II $2,836,489.00 1

Award List:

Agonists of the RIG-I Innate Immune Pathway

Award Year / Program / Phase: 2008 / SBIR / Phase I
Agency: HHS
Principal Investigator:
Award Amount: $585,307.00
Abstract:
DESCRIPTION (provided by applicant): There is a tremendous commercial demand for new antiviral products with novel mechanisms of action and which target a broad spectrum of viruses. Most previous and ongoing pharmaceutical development programs involve scre ening for inhibitors of essential virus… More

Development of Kv1.3 channel blocker ShK-186 as a therapy for multiple sclerosis

Award Year / Program / Phase: 2010 / SBIR / Phase I
Agency: HHS
Principal Investigator: Shawn P. Iadonato
Award Amount: $599,443.00
Abstract:
DESCRIPTION (provided by applicant): Multiple sclerosis (MS) affects approximately 400,000 Americans and constitutes a progressive, disabling disease for which current therapies are inadequate. This application describes the nonclinical development of ShK- 186, a novel Kv1.3 potassium channel… More

Agonists of the RIG-I Innate Immune Pathway

Award Year / Program / Phase: 2011 / SBIR / Phase II
Agency: HHS
Principal Investigator: Shawn P. Iadonato – 206-378-0400
Award Amount: $2,836,489.00
Abstract:
DESCRIPTION (provided by applicant): Through Phase I studies, we have identified five lead small molecule compounds with drug-like properties that activate innate immune response pathways and inhibit the replication of RNA viruses such as hepatitis C virus (HCV), influenza virus (FLU), and West… More